Navigation Links
Pharmacyclics Reports Financial Results and Recent Developments for Fiscal Year and Fourth Quarter 2011 - Conference Call Set for Today at 4:30 PM EDT
Date:9/12/2011

ophosphamide and rituximab; or BR = bendamustine and rituximab) in subjects with CLL or SLL lymphoma. This trial is active in several US sites and completed enrollment with 30 of 30 patients to the BR cohort. We anticipate providing an update of safety results from this study concurrent with releases that are planned for calendar Q4 2011.
  • PCYC-1109:  A Phase IB/II study of PCI-32765 in combination with ofatumumab in subjects with relapsed or refractory CLL or SLL is ongoing and enrolled 33 patients as of the end of August, 2011. We anticipate providing an update on safety results from this study concurrent with releases that are planned for calendar Q4 2011.

  • Ongoing pre-clinical studies, both internally as well as through external collaborations, have suggested a potentially vital role for Btk in both malignant plasma cells and osteoclasts, which are involved in the bone complications of this disease. Therefore, we believe that Btk represents a viable therapeutic target in Multiple Myeloma and we are on track to initiate a Phase II trial of PCI-32765 in this disease in Q1 of calendar 2012.

  • Factor VIIa InhibitorA multicenter Phase I/II of PCI-27483 in patients with locally advanced or metastatic pancreatic cancer that are either receiving or are planned to receive gemcitabine therapy is currently ongoing.  The Phase II portion of the study is enrolling and patients are being randomized to receive either gemcitabine alone or gemcitabine plus PCI-27483. The objectives is to assess the safety of FVIIa Inhibitor PCI-27483 at pharmacologically active dose levels, to assess potential inhibition of tumor progression and to obtain initial information of the effects on the incidence of thromboembolic events. Currently we have enrolled 23 patients in the Phase II portion of this trial and we expect to complete enrollment of our planned 40 patients by Q1 of calendar 2012.

    Histone Deacetylase (HDAC) Inhibito
    '/>"/>

    SOURCE Pharmacyclics, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. Pharmacyclics Announces Date of Fiscal Year End 2011 Financial Results and Conference Call
    2. Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765
    3. Pharmacyclics Announces Oral Presentations and Clinical Update at Upcoming Medical Meetings
    4. Pharmacyclics to Announce Third Quarter Fiscal 2011 Results and Host a Conference Call on May 4, 2011
    5. Pharmacyclics to Announce Second Quarter Fiscal 2011 Results and Host a Conference Call on February 4, 2011
    6. Pharmacyclics Reports Updated Clinical Results from its Phase IA Trial of its First in Human Btk-Inhibitor PCI-32765
    7. Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765
    8. Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010
    9. Pharmacyclics Announces Date of Fiscal Year End 2010 Financial Results and Conference Call and Presentation at Stifel Nicolaus Healthcare Conference
    10. Pharmacyclics to Present at Bank of America Merrill Lynch Healthcare Conference and MDB Bright Lights Conference
    11. Pharmacyclics to Present at the RBC Capital Markets Healthcare Investor Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/24/2014)...  Pifflers United Chronic and Invisible Illnesses Support ... results of a study of ActiPatch®, a new ... fibromyalgia pain. The results demonstrated that when used ... clinically meaningful pain reduction can be achieved. ... used ActiPatch® for 7 days and were then ...
    (Date:11/23/2014)... 23, 2014  Aurobindo Pharma USA ... USP 300 mg 100-count bottles to the consumer level. ... empty capsules. Empty capsules could result in ... that could range from no effect, short term reduction ... (long period seizures) that could be life-threatening. Aurobindo Pharma ...
    (Date:11/22/2014)... N.J. , Nov. 21, 2014  CytoSorbents ... commercializing its European Union approved CytoSorb® cytokine adsorber ... was awarded the Beacon of Light Award at ... Celebration.  Dr. Phillip Chan ... is an honor to be recognized by the ...
    Breaking Medicine Technology:Pifflers United - "Supporting Anyone Living With Chronic/Invisible Illness" Reports ActiPatch Bioelectronic Therapy Relieves Chronic Pain In Fibromyalgia 2Pifflers United - "Supporting Anyone Living With Chronic/Invisible Illness" Reports ActiPatch Bioelectronic Therapy Relieves Chronic Pain In Fibromyalgia 3Aurobindo Pharma USA, Inc. Issues Voluntary Nationwide Recall of Northstar Label Gabapentin Capsules, USP 300 mg Due to Complaints of Empty Capsules 2CytoSorbents Wins Beacon of Light Award 2CytoSorbents Wins Beacon of Light Award 3CytoSorbents Wins Beacon of Light Award 4
    ... , The Danish Statens Serum Institut (SSI) and Intercell, ... I clinical,trial with a tuberculosis (TB) subunit vaccine , , » ... contains Intercell’s,adjuvant IC31™ , , » ... , replace the available TB,vaccine “BCG”/“Calmette vaccine” ...
    ... that its,collaboration partner AtheroGenics, Inc. (Nasdaq: AGIX) ... of Inflammation,Stops Events) phase III clinical outcomes ... with,antioxidant and anti-inflammatory effects, in patients with,coronary ... not meet its primary endpoint of a,statistically ...
    Cached Medicine Technology:Intercell AG: Novel tuberculosis Vaccine Shows Promising,Immunogenicity and Safety Profile 2Intercell AG: Novel tuberculosis Vaccine Shows Promising,Immunogenicity and Safety Profile 3Intercell AG: Novel tuberculosis Vaccine Shows Promising,Immunogenicity and Safety Profile 4Coronary Artery Disease ARISE Trial Showed AGI-1067 Did Not Meet,Primary Endpoint 2
    (Date:11/24/2014)... Dr. Michael Kettel , a leading fertility expert ... to discuss egg freezing as a viable and increasingly accessible ... news recently, with new company benefits at Facebook and Apple ... “[The companies] see it as a way to take care ... Says Dr. Kettel. , Up until a few weeks ago, ...
    (Date:11/23/2014)... November 24, 2014 The clinical ... 2014" provides data on the Aspergillosis clinical trial ... relating to the clinical trials on Aspergillosis. It ... their recruitment status as per the site of ... a preliminary coverage of disease clinical trials by ...
    (Date:11/23/2014)... November 24, 2014 For the coming ... retailer, has launched a great promotion for many products, ... Customers can get the best choice with amazing discounts, ... at Tidebuy.com. , It is easy to buy ... Besides that, this selection is also famous for delicate ...
    (Date:11/23/2014)... November 24, 2014 Tbdress.com has ... available online on Nov. 28, 2014. The special offer will ... , Tbdress.com is one of the world’s largest women’s dresses ... and colors. People can enjoy great discounts on that day: ... enjoy free delivery (for orders above $89). , People can ...
    (Date:11/23/2014)... York, NY (PRWEB) November 23, 2014 ... that allege heart attacks, strokes, deep vein thrombosis ... filed in a federal multidistrict litigation (MDL) underway ... LLP reports. , Court documents updated on ... Multidistrict Litigation (JPML) show the filing of 259 ...
    Breaking Medicine News(10 mins):Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 2Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 3Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 3Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 4Health News:Beautiful Wedding Dresses Available at Popular B2C Company Tidebuy 2Health News:Tbdress.com Special Friday Shoes Sales Online Now 2Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 2Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 3
    ... adults who have alcohol dependence problems drink significantly more than ... has found. The findings suggest that older problem drinkers ... drink even more than younger abusers to achieve the effects ... adults over age 60 who have alcohol dependence drink more ...
    ... Ill., Nov. 20 HealthySkinPortal.com is pleased to announce ... cosmetic skin care providers in the HSP national network, ... SmartLipo(TM) body contouring at its locations in Arizona and ... technologies are constantly being introduced. While some providers choose ...
    ... Nov. 20 Mallika Chopra, healthy living expert and founder ... stress relief products in the US, are teaming up to ... kicks off with advice from Chopra, to be posted today ... holidays without the stress or foreboding that typically comes with ...
    ... , Unique Survey Takes First-Time Look at Employers, ... 20 More employers are taking steps to improve their ... prescribed, a move that could stave off more serious and ... the National Pharmaceutical Council (NPC). , Medication compliance, sometimes ...
    ... electronic health records become more widely deployed, increasing amounts ... many beneficial applications, such as research, public health, and ... Khaled El Emam, the Canada Research Chair in Electronic ... there is a need for robust de-identification of patient ...
    ... ... John,s Riverside Hospital announced it has been granted a full three-year accreditation designation by the ... facility in Westchester County - and one of only four in New York State - ... ...
    Cached Medicine News:Health News:Older problem drinkers use more alcohol than do their younger counterparts 2Health News:Nu U Medspa to Offer Dysport, Zerona, SmartLipo at HealthySkinPortal.com 2Health News:Nu U Medspa to Offer Dysport, Zerona, SmartLipo at HealthySkinPortal.com 3Health News:Survive and Thrive This Holiday Season with Rescue Remedy and Advice from Mallika Chopra 2Health News:Survive and Thrive This Holiday Season with Rescue Remedy and Advice from Mallika Chopra 3Health News:Medication Compliance Is a Key Concern for Employers, According to New Survey 2Health News:Medication Compliance Is a Key Concern for Employers, According to New Survey 3Health News:Ashikari Breast Center Receives Full Accreditation from National Accreditation Program for Breast Centers 2Health News:Ashikari Breast Center Receives Full Accreditation from National Accreditation Program for Breast Centers 3
    ... Ultra has an uniquely designed ... facility in which tubes are ... the same carrying tray. Spin ... magnifier, quiet operation, automatic electric ...
    ... The Rotanta 460 family ... extraordinary line that meets ... demands. They feature high ... Their state-of-the-art technology and ...
    ... Coolscope operates with a simple click ... display. Direct the mouse cursor to ... image of the slide and the ... intuitive Graphic User Interface (GUI) enables ...
    Continuous rocking motion graphic display....
    Medicine Products: